Tag Archive: Raymond G. Perelman Center for Cellular and Molecular Therapeutics

Oct 2 2019

Off Campus: An EMT-on-Skis Comes to the Rescue

By Nancy McCann

Editor’s note: Welcome to our new blog series, “Off Campus.” Here you’ll discover what our amazing Research Institute employees do for fun, recreation, and the good of their communities once they leave the city behind. And if you know someone in your department or lab with a fascinating hobby or interest, we’d like to hear about it!

Read the rest of this entry >>

Sep 20 2019

In the News: Pre-transplant Communication, Working Memory and Driving, Master Regulator Gene in Schizophrenia, Girls’ Concussion Care, Baby Brain Development

A slight chill on the air and the rustling of falling leaves means it’s time to grab your favorite pumpkin spice beverage and read our latest roundup of research news. Investigators from Children’s Hospital of Philadelphia’s Center for Injury Prevention and Research shared findings in concussion research and preventing car crashes among teens. Scientists in the Raymond G. Perelman Center for Cellular and Molecular Therapeutics discovered a gene that could help guide future treatment for schizophrenia, and a pilot grant from the Center for Pediatric Clinical Effectiveness will support aims to improve pre-transplant communication with patients and their families. As you savor the last few sips from your cup, learn about CHOP researchers’ contributions to a special journal issue on baby brain development. 

Read the rest of this entry >>

Dec 21 2018

New Grant Awarded to Study Mechanisms of Clotting

Thrombosis — the abnormal, life-threatening blood clots that form in the artery or vein — does not discriminate. Young. Old. Rich. Poor. Gender. Race. Ethnicity. We’re all in this together. We’re all susceptible. Some more so than others.

Up to 900,000 people in the U.S. are affected by blood clots each year; 100,000 will die, which is greater than the total number of people who lose their lives each year to AIDS, breast cancer, and motor vehicle crashes combined.

Read the rest of this entry >>

Nov 6 2018

Realizing the Promise of Gene Therapy: Q&A With Clinical Vector Core Directors

Read the rest of this entry >>

Oct 8 2018

The Science Behind Gene Therapy: Creating Breakthroughs One Gene at a Time

For more than 20 years, researchers at Children’s Hospital of Philadelphia and the University of Pennsylvania have been at the forefront of taking a system perfected by nature — a virus — and transforming it into breakthrough gene therapies for rare single-gene diseases. CHOP was the first pediatric research institution to develop chimeric antigen receptor T cell (CAR-T) therapy for acute lymphoblastic leukemia. In this approach, viral vectors are used to modify a patient’s own T cells, training them to track down and eliminate the circulating cancer cells.

Read the rest of this entry >>

May 1 2018

Does an Impaired Biological Pathway Help Explain Heart Problems in Huntington’s Disease?

The Findings:

Researchers gained new insights into the heart problems that are the second leading cause of death in patients with Huntington’s disease (HD). An incurable, inherited disease with progressive loss of brain cells and motor function, HD occurs when a defective gene produces repeated copies of a protein called huntingtin, or HTT. The mutant HTT (mHTT) protein disrupts multiple fundamental cellular processes along the mTORC1 pathway that promotes cell growth and metabolism. The study team described how decreased mTORC1 activity contributed to the development of heart disease with stress in mouse models of HD. By restoring cardiac mTORC1 activity, the researchers improved the animals’ heart function and survival over the course of the study.

Read the rest of this entry >>

Dec 21 2017

Groundbreaking Gene Therapy Approved for Inherited Retinal Blindness

More than a decade of studies led by researchers at Children’s Hospital of Philadelphia and the University of Pennsylvania culminated this week with the U.S. Food and Drug Administration’s approval of an innovative one-time gene therapy product indicated for the treatment of patients with a rare, inherited form of retinal blindness.

Read the rest of this entry >>

Jul 29 2016

CHOP Research In the News: New Rare Disease, FA Woodstock, Bioengineering, and Protecting Toddlers from Child Abuse

CHOP Research In the NewsOne of the things that is so exciting about research at CHOP is that our researchers are working to improve the health and lives of children in such a broad range of ways.

Read the rest of this entry >>